AST 0 3 0 3 B-clinical_variable
/ 3 4 3 4 I-clinical_variable
ALT 4 7 4 7 I-clinical_variable
> 8 9 8 9 O
2.5 9 12 9 12 B-lower_bound
x 13 14 13 14 I-lower_bound
ULN 15 18 15 18 I-lower_bound

Acute 0 5 19 24 B-chronic_disease
major 6 11 25 30 I-chronic_disease
illness 12 19 31 38 I-chronic_disease
( 20 21 39 40 O
e.g. 21 25 40 44 O
, 25 26 44 45 O
unstable 27 35 46 54 B-chronic_disease
cardiovascular 36 50 55 69 I-chronic_disease
condition 51 60 70 79 I-chronic_disease
, 60 61 79 80 O
etc 62 65 81 84 O
. 65 66 84 85 O
) 66 67 85 86 O

Age 0 3 87 90 B-age
between 4 11 91 98 O
21 12 14 99 101 B-lower_bound
- 14 15 101 102 O
90 15 17 102 104 B-upper_bound

Albumin 0 7 105 112 B-clinical_variable
< 8 9 113 114 O
3 10 11 115 116 B-upper_bound
g 12 13 117 118 I-upper_bound
/ 13 14 118 119 I-upper_bound
dl 14 16 119 121 I-upper_bound

Bilirubin 0 9 122 131 B-clinical_variable
> 10 11 132 133 O
1.5 12 15 134 137 B-lower_bound
x 16 17 138 139 I-lower_bound
( 18 19 140 141 I-lower_bound
ULN 19 22 141 144 I-lower_bound
) 22 23 144 145 I-lower_bound

GT 0 2 146 148 B-clinical_variable
> 3 4 149 150 O
2.5 5 8 151 154 B-lower_bound
x 9 10 155 156 I-lower_bound
ULN 11 14 157 160 I-lower_bound
IF 15 17 161 163 O
Alkaline 18 26 164 172 B-clinical_variable
phosphatase 27 38 173 184 I-clinical_variable
> 39 40 185 186 O
2.5 41 44 187 190 O
x 45 46 191 192 O
ULN 47 50 193 196 O

Hepatic 0 7 197 204 O
: 7 8 204 205 O
from 9 13 206 210 O
assays 14 20 211 217 O
obtained 21 29 218 226 O
< 30 31 227 228 O
2 31 32 228 229 B-upper_bound
weeks 33 38 230 235 I-upper_bound
prior 39 44 236 241 I-upper_bound
to 45 47 242 244 O
study 48 53 245 250 O
enrollment 54 64 251 261 O
For 65 68 262 265 O
each 69 73 266 270 O
patient 74 81 271 278 O
, 81 82 278 279 O
the 83 86 280 283 O
upper 87 92 284 289 B-clinical_variable
limit 93 98 290 295 I-clinical_variable
of 99 101 296 298 I-clinical_variable
normal 102 108 299 305 I-clinical_variable
( 109 110 306 307 I-clinical_variable
ULN 110 113 307 310 I-clinical_variable
) 113 114 310 311 I-clinical_variable
value 115 120 312 317 O
for 121 124 318 321 O
a 125 126 322 323 O
particular 127 137 324 334 O
assay 138 143 335 340 O
will 144 148 341 345 O
be 149 151 346 348 O
defined 152 159 349 356 O
by 160 162 357 359 O
the 163 166 360 363 O
normal 167 173 364 370 O
reference 174 183 371 380 O
values 184 190 381 387 O
of 191 193 388 390 O
the 194 197 391 394 O
laboratory 198 208 395 405 O
that 209 213 406 410 O
performed 214 223 411 420 O
the 224 227 421 424 O
assay 228 233 425 430 O

Inability 0 9 431 440 O
or 10 12 441 443 O
refusal 13 20 444 451 O
to 21 23 452 454 O
have 24 28 455 459 O
at 29 31 460 462 O
least 32 37 463 468 O
one 38 41 469 472 B-lower_bound
peripheral 42 52 473 483 O
intravenous 53 64 484 495 O
line 65 69 496 500 O
for 70 73 501 504 O
intravenous 74 85 505 516 O
access 86 92 517 523 O
( 93 94 524 525 O
as 94 96 525 527 O
applicable 97 107 528 538 O
to 108 110 539 541 O
the 111 114 542 545 O
day 115 118 546 549 O
of 119 121 550 552 O
[ 122 123 553 554 B-treatment
18F 123 126 554 557 I-treatment
] 126 127 557 558 I-treatment
4 128 129 559 560 I-treatment
- 129 130 560 561 I-treatment
L 130 131 561 562 I-treatment
- 131 132 562 563 I-treatment
Fluoroglutamine 132 147 563 578 I-treatment
( 148 149 579 580 I-treatment
2S,4R 149 154 580 585 I-treatment
) 154 155 585 586 I-treatment
injection 156 165 587 596 I-treatment
and 166 169 597 600 I-treatment
blood 170 175 601 606 I-treatment
draws 176 181 607 612 I-treatment
. 181 182 612 613 O
) 182 183 613 614 O

Refusal 0 7 615 622 O
or 8 10 623 625 O
inability 11 20 626 635 O
to 21 23 636 638 O
tolerate 24 32 639 647 O
the 33 36 648 651 O
scanning 37 45 652 660 O
procedure 46 55 661 670 O
( 56 57 671 672 O
e.g. 57 61 672 676 O
, 61 62 676 677 O
due 63 66 678 681 O
to 67 69 682 684 O
claustrophobia 70 84 685 699 B-chronic_disease
) 84 85 699 700 O

Renal 0 5 701 706 O
: 5 6 706 707 O
Creatinine 7 17 708 718 B-lower_bound
> 18 19 719 720 O
1.5 19 22 720 723 B-lower_bound
x 23 24 724 725 I-lower_bound
ULN 25 28 726 729 I-lower_bound
or 29 31 730 732 O
creatinine 32 42 733 743 B-clinical_variable
clearance 43 52 744 753 I-clinical_variable
< 53 54 754 755 O
60 55 57 756 758 B-upper_bound
mL 58 60 759 761 I-upper_bound
/ 60 61 761 762 I-upper_bound
min 61 64 762 765 I-upper_bound
, 64 65 765 766 O
from 66 70 767 771 O
assays 71 77 772 778 B-clinical_variable
obtained 78 86 779 787 O
< 87 88 788 789 O
2 88 89 789 790 B-upper_bound
weeks 90 95 791 796 I-upper_bound
prior 96 101 797 802 I-upper_bound
to 102 104 803 805 O
study 105 110 806 811 O
enrollment 111 121 812 822 O

egative 0 7 823 830 B-pregnancy
serum 8 13 831 836 I-pregnancy
pregnancy 14 23 837 846 I-pregnancy
test 24 28 847 851 O
for 29 32 852 855 O
female 33 39 856 862 B-gender
patients 40 48 863 871 I-gender
of 49 51 872 874 O
childbearing 52 64 875 887 O
age 65 68 888 891 B-age
and 69 72 892 895 O
potential 73 82 896 905 O
( 83 84 906 907 O
as 84 86 907 909 O
defined 87 94 910 917 O
by 95 97 918 920 O
MSKCC 98 103 921 926 O
Standards 104 113 927 936 O
& 114 115 937 938 O
Guidelines 116 126 939 949 O
) 126 127 949 950 O
, 127 128 950 951 O
from 129 133 952 956 O
assays 134 140 957 963 O
obtained 141 149 964 972 O
< 150 151 973 974 O
2 151 152 974 975 B-upper_bound
weeks 153 158 976 981 I-upper_bound
prior 159 164 982 987 I-upper_bound
to 165 167 988 990 O
study 168 173 991 996 O
enrollment 174 184 997 1007 O

history 0 7 1008 1015 O
of 8 10 1016 1018 O
histologically 11 25 1019 1033 O
- 25 26 1033 1034 O
confirmed 26 35 1034 1043 O
solid 36 41 1044 1049 B-cancer
malignancy 42 52 1050 1060 I-cancer
and/or 53 59 1061 1067 O
lymphoma 60 68 1068 1076 B-cancer
( 69 70 1077 1078 O
histology 70 79 1078 1087 O
confirmed 80 89 1088 1097 O
by 90 92 1098 1100 O
MSKCC 93 98 1101 1106 O
Department 99 109 1107 1117 O
of 110 112 1118 1120 O
Pathology 113 122 1121 1130 O
. 122 123 1130 1131 O
) 123 124 1131 1132 O

